Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Under the Medicare GLP-1 Bridge pilot program running from July 1, 2026, through December 31, 2027, certain Medicare recipients can access Wegovy for $50 per month (reflecting a 50% co-pay)
doi:10.1038/s41583-023-00724-7
Its ability to modulate the inflammatory response also contributes to its effectiveness in reducing pain and promoting recovery
Tirzepatide is a once-weekly injectable medication that simultaneously activates two hormone receptors: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)
US$ 26.27
US$ 24.38
US$ 20.16
US$ 27.59
US$ 20.55
US$ 23.34
